Objective: To define distinctive features of nodular heterotopia in specimens derived from drugresistant patients with epilepsy by evaluating mRNA expression of three different layer-specific markers: Ror␤, Er81, and Nurr1.
ugh their use is increasing in rodents and monkeys, [20] [21] [22] [23] [24] [25] their testing on human neuropathologic material is limited. [26] [27] [28] In the present study, we analyzed the expression patterns of 3 layer-specific genes, namely Ror␤, Er81, and Nurr1, in control human tissues and in tissues from patients with subcortical NH to provide insight into the structural organization of the heterotopia.
METHODS Patient and specimen selection. Samples
were obtained from 14 drug-resistant patients operated on for intractable epilepsy at the Epilepsy Surgery Center of Niguarda Hospital, as described in previous articles. 7, 29 The clinical histories of all patients were reviewed including the presence of antecedents, age at seizure onset, seizure frequency, imaging data, and outcome after surgery. Invasive presurgical stereo-EEG was performed in 10 patients in order to precisely define the epileptogenic zone. Surgery was performed for strictly therapeutic reasons in order to remove accessible brain areas involved in seizure generation and only after informed consent. Cortical specimens were divided into 2 groups: 1) samples not exhibiting morphologic alterations were used as controls to test the expression of the genes and to verify the possible differences in 2 different cortical areas (temporal and frontal; 8 cases); and 2) samples with SCH as defined by MRI and neuropathologic studies (6 cases). The table summarizes the main clinical features of these patients.
Standard protocol approvals, registration, and patient consents. The local Medical Ethical Committee approved the study, and all patients gave written informed consent to use cerebral specimens for research.
Immunocytochemistry and in situ hybridization. Specimens were fixed in 10% neutral buffered formalin and em-bedded in paraffin. Sections (4-to 10-m thick) were cut and stained using routine histochemical procedures; additional series were processed for immunolocalization. In all cases, specimens adjacent to those processed for routine neuropathology were fixed in 4% paraformaldehyde, vibratome cut into 50m-thick serial sections, and processed (as previously described 16 ) for immunocytochemistry and for in situ hybridization (ISH).
To investigate the expression of Ror␤, Er81, and Nurr1 genes, the cDNA fragments were obtained by polymerase reaction using the primers listed elsewhere. 24, 25 Subsequently the cDNA were subcloned into the pBlueScriptII vector. The digoxigenin (DIG)-labeled riboprobes were produced using these plasmids as templates for in vitro transcription. Freefloating sections were permeabilized with Triton X-100 0.3% in phosphate buffer and blocked in 0.75% glycine. After rinsing, they were incubated in a hybridization buffer (5ϫ standard saline citrate [SSC]/50% formamide/2% blocking reagent [Roche Diagnostics, Mannheim, Germany]/0.1% N-lauroylsarcosine [NLS]/ 0.1% sodium dodecyl sulfate) containing 1 g/mL DIG-labeled heat-denatured riboprobes overnight at 60°C. The sections were washed in 2ϫ SSC/50% formamide/0.1% NLS and treated with 20 g/mL RNaseA (Roche Diagnostics) in RNase buffer for 30 minutes at 37°C. After washing in 2ϫ SSC/0.1% NLS and in TS buffer (100 mM Tris/HCl/150 mM NaCl), the sections were incubated with 1% blocking reagent in TS pH 7.5 and then with an alkaline phosphatase-conjugated anti-DIG antibody (1:1,000, Roche Diagnostics) in 1% blocking reagent overnight at 4°C. After washing in TS pH 7.5/0.05% Tween 20 and in TS pH 9.5, the antibody visualization was made with 1/50 NBT/BCIP (Roche Diagnostics) in TS pH 9.5 in the dark for almost 30 minutes. The reaction was stopped in PBS/10 mM EDTA. Finally, the sections were mounted, dehydrated, and covered with Crystal Mount (Sigma, St. Louis, MO). There were no apparent signals in control sections with the sense probes.
The distribution of Ror␤, Er81, and Nurr1 genes in 2 subcortical nodules (patients 9 and 10) was plotted. For each marker, the ISH-stained section was viewed with a 4ϫ objective and using Image Pro-Plus 6.2 software (Media Cybernetics, Bethesda, MD) a series of contiguous images was captured forming a single tiled image containing the entire nodule. The cells positive for the genes were separately plotted onto a blank layer as dots of different colors. Three blood vessels, conserved across the different sections, were used as landmarks to superimpose the ISH-stained sections.
Double fluorescence ISH/ICC. Selected sections from controls were processed for ISH using Ror␤, Er81, and Nurr1 probes combined with immunocytochemistry using anti-NeuN antibody. The first part of the experiment was carried out as described above. After blocking, sections were incubated with a mixture of rabbit anti-DIG antibody (1:100,000, Sigma) and mouse anti-NeuN antibody (1:3,000, Chemicon, Temecula, CA). After several washings (in TS pH 7.5/0.05% Tween 20), sections were incubated both with biotinylated anti-rabbit secondary antibody (1:200, Vector, Burlingame, CA) and indocarbocyanine (Cy) 3-conjugated goat anti-mouse secondary antibody (1:500, Jackson Immunoresearch Laboratories, West Grove, PA) in 1% blocking reagent in TS pH 7.5 for 60 minutes at room temperature. After washing in TS pH 7.5, they were treated with 3% H 2 O 2 in TS pH 7.5 and incubated with Streptavidine-HRP (1:1,000, PerkinElmer, Boston, MA) in 1% blocking reagent in TS pH 7.5 for 30 minutes at room temperature and then with Biotinil-Tyramide fluorescinated in amplification reagent (1:50, PerkinElmer) for 3 minutes at room temperature. Finally, the sections were washed in TS pH 7.5/ 0.05% Tween 20 3 times for 15 minutes and mounted with Fluor Safe (Calbiochem, San Diego, CA).
Semiquantitative analysis of ISH signals.
We restricted the quantification of gene expression to the lateral temporal cortex corresponding to T2-T3 gyri in order to compare the same region among the cases: 3 control (patients 1, 2, 5) and 2 SCH (patients 9, 10). In SCH cases, the temporal cortex studied was overlying the nodules. Cell counts were performed using Image Pro-Plus 6.2 software. The number of Ror␤-, Er81-, and Nurr1-positive cells was evaluated using 2-dimensional cell counting technique; for cytoarchitectonic determination of cortical layers NeuN immunolabeled adjacent sections were used. To estimate the ratio of cell population expressing layer-specific markers to total neurons in each lamina, we counted NeuN-positive neurons. For each case and for each marker, 3 images randomly sampled were captured through a 4ϫ objective. The area including the layer of interest was manually outlined using NeuN-stained section and all cells within this area were manually counted applying zoom factor 4 to the captured images. A parallel quantization on ISH-stained sections on identical areas was performed ( (table) . The neuropathologic analysis showed the presence of low-grade tumors in 3 patients, and no evident histopathologic lesion in 4 (cryptogenic). Hippocampal sclerosis was found in the remaining patient. In the cortical samples from all these patients, the morphologic analysis revealed preserved cortical layering and the absence of morphologic abnormalities; therefore, these specimens were used as controls.
Riboprobe expression in control human cortex. ISH experiments showed expression of Ror␤, Er81, and Nurr1 in all the specimens and the laminar localization of each gene was assessed by comparing the ISH pattern with thionin-stained and NeuNimmunoreacted adjacent sections ( figure 1A) . Ror␤ mRNA was intensely expressed in layer IV ( figure  1B) where labeled cells appeared densely packed and tended to be arranged in microcolumns. A lower Ror␤ mRNA expression was also observed in scattered cells in layers III and V. Er81-labeled cells were mainly concentrated in layer V ( figure 1C ), although scattered labeled neurons were also observed in the neighboring layers. 11, 14) . Moreover, in 2 cases (patients 11, 12), part of the cortex was infiltrated by nodules. Regardless of size, lobe, or depth location, the heterotopic nodules were composed of irregularly distributed pyramidal and nonpyramidal neurons, and moderate gliosis was always present, particularly around blood vessels. 7, 16 Riboprobe expression in SCH. In all cases, layerspecific markers were expressed in the cortex (figure 2, B-D) and in the heterotopic nodules ( figure 3 ; figures e-1 and e-2). In the overlying cortex, except in areas where nodules invade the gray matter, the laminar localization of each gene was similar to that observed in control cortex but the labeled cells appeared less numerous and more widespread ( figure 2, B-D) . In fact, Ror␤-positive cells represented 50% of layer IV neurons, Er81-positive cells were 31% of layer V neurons, and Nurr1positive cells were 16% of layer VI neurons ( figure  2E and table e-1). In the 2 cases where nodules infiltrate the overlying cortex, the riboprobes distribution was completely disrupted with no identifiable laminar organization (figure e-2). Within the nodules in the white matter, in all cases but 1 (patient 11), no striking differences in the distribution of the layer-specific markers were observed. Few Nurr1-positive cells were present and those were confined to the outer border (figure 3, F-H, and figure e-1, G-I). Er81-positive cells were more numerous and partially intermingled with those labeled by Nurr1, although in a more extensive area than Nurr1-positive cells (figure 3, I-K, and figure e-1, J-L). Ror␤-expressing cells were preferentially concentrated in the central part of the nodules (figure 3, L-N, and figure e-1, M-O) . The core of some nodules was devoid of labeled cells by any of the 3 markers. This pseudostratified anatomic organization was clearly visible when cells labeled by each riboprobe were plotted ( figure 4 ).
DISCUSSION
The current report investigates the expression pattern of 3 layer-specific genes in patients with drug-resistant epilepsy and shows that 1) the selected genes exhibit very high layer specificity; 2) their relative layer position is generally conserved across different areas; and 3) a rudimental laminar organization occurs within the subcortical nodules.
Many molecules with layer-related expression patterns have been identified and some of them, such as cytoskeletal proteins and calcium-binding proteins, are expressed in multiple layers and are often used for studies on human samples. Conversely, layer-specific genes seem to exhibit very high laminar specificity in rodents and monkeys although scattered labeled cells with low hybridization signal can be detected also in adjacent layers. [20] [21] [22] [23] [24] [25] Few reports have investigated the expression patterns of layer-specific genes in adult normal human cortex. 27, 28 The present study, confirming the prevalent expression of Ror␤ mRNA in layer IV in human temporal cortex, 28 extends this observation to other cortical areas and reports the expression of Nurr1 and Er81 genes in human neocortical samples. The data obtained in control samples demonstrate a distribution of the 3 layer-specific genes similar to that reported in monkey cortex. 24 Moreover, the data show that most of the neurons in layer IV express Ror␤ mRNA; by contrast, Nurr1 and Er81 mRNA are only present in a subpopulation of neurons in layers V and VI as previously suggested. 24 The neuropathologic features and organization of NH, in patients with proven filamin 1 mutation 14, 15 and in those with no demonstrated genetic mutation, are very similar, suggesting that the final structure of the nodules is independent from their genetic etiology and unrelated to their extent and location. 7, 15, 16 In animal models, 18, 19 sharing some similarities with human nodular heterotopia, birth-dating with bromodeoxyuridine revealed neurogenetic gradients in the heterotopia, with early generated neurons mainly located in the external regions and late generated cells mainly restricted to the internal areas of the heterotopia. These data suggest that neurogenesis seems to follow the same ontogenetic rule of cortical layering formation. Moreover, the possible laminar organiza-tion of the heterotopia has been suggested recently. 15, 20 In line with this hypothesis, we demonstrate the prevalent expression of neurons belonging to layer VI and V (Nurr1-and Er81-positive cells) in the external border of the nodules with those belonging to layer IV (Ror␤-positive cells) in a more internal region. Although markers with specific expression patterns in the supragranular layers have not been used in the present study, we can predict that the central core of the nodules, in some cases not labeled by any of the 3 markers, will be occupied by cells expressing supragranular cell markers. The presence of neurons belonging to the supragranular layer has been recently demonstrated in patients with periventricular heterotopia, 17 with the presence of neurons immunoreactive for Cux1 (marker for layers II-III), while neurons belonging to deep layers, identified by FOXP1 antibody, are scarcely expressed. This discrepancy with our results could be ascribed to different technical approaches (immunocytochemistry vs ISH) or to different material (autoptic vs surgical samples). What remains to be explained is how the nodules can be organized in a (rudimentary) laminar pattern. Changes in neuronal gene expression could not be completely ruled out by our study, but we consider this possibility unlikely since the laminar expression of these genes in the overlying cortex of each patient is preserved. Cortical architecture is primarily established by radially migrating neurons that accumulate in the cortical plate (CP) in an inside-out sequence. The first stratum formed, the primordial plexiform layer (PPL), includes Cajal-Retzius cells that produce reelin, recognized as fundamental for the correct formation of cortical layers. With the arrival of the first cohort of postmitotic neurons that will form the CP, the PPL splits into two transient layers: the marginal zone above (future layer I) and the subplate (SP) below the emerging CP. The SP is also a transient layer where the residing neurons, during development, progressively disappear by a programmed cell death mechanism. 30 Based on this acquired developmental knowledge, we could hypothesize that in SCH some of the Cajal-Retzius cells remain located also in the SP. Thus Cajal-Retius cells wrongly located in this transient layer will attract migrating neurons in a heterotopic position leading to a rudimentary laminar organization. In line with this hypothesis is a report 15 on the presence of cell-free zones with small vessels and glial cells with radiating fibers, reminiscent of layer I, within the core of the heterotopia. This mechanism would also account for the reduced number of labeled cells in the overlaying cortex of SCH as observed in the present experiments. We suggest that layer-specific markers can be fruitfully used in human material derived from surgical specimens and have the potential to provide insights into the pathogenesis of MCD. 
